Abstract

These slides were presented by Janssen Pharmaceutical Companies of Johnson & Johnson at the ACIP extraordinary meeting on February 28th 2021.

  • Background paper
  • Americas
  • United States of America
  • Janssen COVID-19 Vaccine
  • COVID-19